Oral Submucous Fibrosis
14
1
1
8
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 40/100
0.0%
0 terminated out of 14 trials
100.0%
+13.5% vs benchmark
21%
3 trials in Phase 3/4
0%
0 of 8 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 8 completed trials
Clinical Trials (14)
Fibrosis-Modulating Effects of Metformin and Pirfenidone in Oral Submucous Fibrosis
Alternating Triamcinolone and Platelet-Rich Plasma Therapy for Oral Submucous Fibrosis
Metformin Repurposing in Oral Submucous Fibrosis: Unveiling In Vitro Signaling Pathways, Progressing to Clinical Trial
Comparison of Curcumin and Intralesional Steroids in Oral Submucous Fibrosis
Effect of Laser Photobiomodulation in Improving Mouth Opening in Oral Submucous Fibrosis
Comparative Effect of Nigella Sativa and Conventional Management for OSMF
Oral Cancer Screening and Education in Hong Kong
Oral Epithelial Dysplasia Informational Needs Questionnaire
Epithelial Mesenchymal Transition Markers in OSMF
Efficacy of Curcumin in Oral Submucous Fibrosis
Evaluation of Auto Antibodies in Oral Sub Mucous Fibrosis
Evaluation of Efficacy of Aloevera in the Treatment of Oral Submucous Fibrosis- A Clinical Study
Use of Single Staged Nasolabial Flap in Oral Submucous Fibrosis
Topical Application of Curcumin Orabase in Oral Submucous Fibrosis (OSMF)